DENGUE

This study tests a dengue vaccine in healthy adults aged 60 to 79 and compares their immune response to that of adults aged 40 to 59. The goal is to see if the vaccine works as well and is as safe in older adults. About 997 participants will receive one dose and be followed for s…

This study tests a new medicine called CP-COV03 in adults with dengue fever. The goal is to see if it safely reduces the virus and speeds up recovery. About 210 participants will receive either the drug or a placebo. The trial is currently recruiting.

This study tests an experimental drug called EYU688 in 108 adults with dengue fever. The goal is to see if it can lower the amount of virus in the blood and shorten the time fever lasts compared to a placebo. Participants must have had a fever for less than 48 hours and test posi…

This study tests experimental antiviral drugs in people with early dengue fever (less than 48 hours of symptoms). The goal is to see if these drugs can lower the amount of virus in the blood and reduce illness severity. About 500 participants will be enrolled and closely monitore…

This study follows 100 people with confirmed dengue fever to figure out which symptoms and lab results predict the need for hospital care. Researchers will also track how often blood transfusions are given and what happens afterward. The goal is to help doctors make better decisi…

This study will safely give a weakened dengue virus to 5 healthy adults in Singapore to learn how the body fights the infection. Researchers will track symptoms, virus levels, and immune responses over time. The goal is to create a reliable model for testing future dengue vaccine…

This study will test 10,000 people in Cambodia for antibodies to over 50 different infectious diseases, including dengue, flu, and malaria. The goal is to map where and how these diseases spread in communities, involving people aged 2 to 75 who have lived in a village for at leas…